publication venue for PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines. 1661-1669. 2022 The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. 2110-2117. 2022